The FDA Safety and Landmark Advancements (FDASLA) Act has passed a key committee, with 25 out of some 30 amendments passing. Generics and baby formula crisis got most of the attention.
Harry Moser of the Reshoring Initiative gives his assessment of America’s reshoring efforts in testimony to the U.S. China Economic and Security Review Commission.
Deborah Rosenblum of the Department of Defense tells the U.S. China Economic and Security Review Commission that Washington has to reshore critical supply chains.
The U.S. China Economic and Security Review Commission asked panelists to discuss just how powerful, and important, China supply chains have become to the U.S. economy.
The U.S. China Economic and Security Review Commission heard from panelists this week on Washington’s reshoring efforts. Question: Will there be any buyers?
The White House says more solar imports will help spread environmental justice in the U.S. Is Southeast Asia our new Environmental Justice League?
Voters support locally made solar. So why is the Biden administration giving China companies under investigation for trade violations in SE Asia duty-free access to the U.S.?
The Food and Drug Administration recently updated its drug shortage list. More than half of the updates include drugs on the essential medicines list.
Senator Burr warned the FDA that until the Senate is okay with their response to the infant formula crisis, and present a plan to prevent it in the future, the Generic Drug User Fee Authorization bill might be put on hold.
Press reports say that Treasury Secretary Janet Yellen is arguing for repealing a broad set of U.S. tariffs, allegedly as a way to fight inflation.
